Chemclin Diagnostics Co., Ltd. (SHA:688468)
China flag China · Delayed Price · Currency is CNY
7.39
+0.15 (2.07%)
Apr 29, 2026, 2:45 PM CST

Chemclin Diagnostics Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
43.91127.07147.37152.63142.76
Depreciation & Amortization
56.553.3949.2951.2152.98
Other Amortization
4.874.693.323.064.06
Loss (Gain) From Sale of Assets
-0.12-0.51-0.18-0.070.1
Asset Writedown & Restructuring Costs
8.54.122.832.152.32
Loss (Gain) From Sale of Investments
-8.84-11.52-14.77-19.58-12.6
Provision & Write-off of Bad Debts
--0.2-0.410.020.14
Other Operating Activities
-1.037.861.221.971.22
Change in Accounts Receivable
9.3526.763.826.8222.39
Change in Inventory
-7.5-1.341.127.95-25.15
Change in Accounts Payable
-8.24-31.44-11.5526.114.6
Change in Other Net Operating Assets
---17.45-
Operating Cash Flow
93.9167.95173.05244.56188.86
Operating Cash Flow Growth
-44.09%-2.95%-29.24%29.49%24.29%
Capital Expenditures
-69.88-107.49-301.37-125.28-72.55
Sale of Property, Plant & Equipment
0.370.220.030.020.04
Investment in Securities
-26-39-22-10-252
Other Investing Activities
9.3712.2115.6620.7613.97
Investing Cash Flow
-86.14-134.06-307.68-114.5-310.54
Long-Term Debt Issued
-23.71196.48--
Long-Term Debt Repaid
-20-8.12-13.33-11.78-11.09
Net Debt Issued (Repaid)
-2015.59183.16-11.78-11.09
Issuance of Common Stock
-0.85--261.35
Repurchase of Common Stock
--51.09---
Common Dividends Paid
-54.79-53.28-139.15-68.17-
Other Financing Activities
-23.51----8.26
Financing Cash Flow
-98.3-87.9344.01-79.95242
Foreign Exchange Rate Adjustments
-0.110.070.080.4-0.1
Net Cash Flow
-90.65-53.97-90.5450.51120.22
Free Cash Flow
24.0160.46-128.32119.28116.31
Free Cash Flow Growth
-60.28%--2.55%69.43%
Free Cash Flow Margin
7.22%13.86%-28.81%25.64%24.71%
Free Cash Flow Per Share
0.060.15-0.320.300.30
Cash Income Tax Paid
40.4969.8796.5762.962.44
Levered Free Cash Flow
-222.9610.56-169.5493.2957.47
Unlevered Free Cash Flow
-222.9613.84-169.2593.6157.93
Change in Working Capital
-9.91-16.95-15.6253.18-2.12
Source: S&P Global Market Intelligence. Standard template. Financial Sources.